Sobi appoints chief operating officer

Alan Raffensperger takes over sales & marketing, supply chain, procurement and IT

Alan Raffensperger has joined Swedish Orphan Biovitrum (Sobi) as chief operating officer with responsibility for sales & marketing, supply chain, procurement and IT.

Most recently he was chief executive of Benechill, a US medical device company within the hypothermia therapeutic field. From 2005–2010 he was employed by Amgen and served as executive director, Head of Nephrology from 2008–2010 based at the international headquarters in Switzerland, and general manager of the Nordic and Baltic region 2005–2008, based in Sweden.

Raffensperger was sales and marketing director at Roche Pharmaceuticals, Sweden 1999–2004; vice president, Global Marketing Diabetes Care at Roche Diagnostics 1996–1998 based in Germany, and business director Europe, Diabetes Care at Boeringher Mannheim 1994–1996, also based in Germany. He has also held leading positions within Pharmacia in Sweden and the US.

Sobi is an integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the health of rare disease patients and their families. Its product portfolio consists of around 60 marketed products as well as projects in the late clinical phase. Key therapeutic areas are inflammation and genetics and metabolism.

You may also like

Research & Development

Sobi Orfadin capsules approved in Saudi Arabia

Swedish Orphan Biovitrum's orfadin capsules approved in the Kingdom of Saudi Arabia for the treatment of hereditary tyrosinemia type 1
Manufacturing

Sobi signs manufacturing agreements with Pfizer

Sobi is dedicated to developing and delivering innovative therapies for rare diseases
Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Ingredients

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Research & Development

The IND advantage: why early derisking is a strategic imperative for complex biologics

As biologics grow more complex, early identification and the mitigation of manufacturability, stability and immunogenicity risks have become the critical factor separating programmes that reach IND on time from those that don't, says Yvette Stallwood, Head of Early Development Services at Lonza
Pharmaceutical

CellCarta and Leica Biosystems expand companion disgnostic development model partnership

Building on a successful CDx joint development model in China, the pair will aim to bring the end-to-end development framework to global customers to help their customers streamline the path to global CDx commercialisation
Manufacturing

ystral opens ATEX-compliant trial centre in Germany to expand customer process development capacity

The new facility, based in Ballrechten-Dottingen, will be able to handle flammable and explosive media testing across pharma, coatings and food applications, with remote livestream access and in-house particle size and viscosity analysis
Subscribe now